News & Updates
Filter by Specialty:
High blood manganese tied to weaker bones
Blood manganese concentrations show a negative association with bone mineral density (BMD) and bone mineral content (BMC), suggesting that the metal may play a role in osteoporosis and osteopaenia, a recent study has found.
High blood manganese tied to weaker bones
29 Oct 2022
Dog owners ward off asthma against risk allele carriers
Among individuals carrying the 17q12-21 asthma-risk variant rs2305480, owning a dog appears to exert a protective effect against persistent wheeze, a recent study has found.
Dog owners ward off asthma against risk allele carriers
29 Oct 2022
Carbapenem-sparing cephamycins effective in E coli-induced UTI
Cefmetazole and cefoxitin prove to be effective in the treatment of patients with urinary tract infections (UTIs) due to extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli, according to two separate studies presented at IDWeek 2022.
Carbapenem-sparing cephamycins effective in E coli-induced UTI
28 Oct 2022
Unmet social needs linked to overactive bladder
Some social needs that are not properly addressed may contribute to the presence of overactive bladder (OAB) in adults, and these unmet needs can affect the overall management of OAB patients, suggests a recent study.
Unmet social needs linked to overactive bladder
28 Oct 2022
Cemiplimab shows favourable signals as first-, second-line treatment alternative for NSCLC
In the 3-year follow-up of the EMPOWER-Lung 1 study, first-line cemiplimab continued to outdo chemotherapy (CT) in providing survival benefit for patients with advanced non-small-cell lung cancer (NSCLC). Moreover, in the second-line setting (patients with progressive disease [PD]), cemiplimab added to CT provided meaningful and durable objective response rate (ORR) and overall survival (OS) benefit.
Cemiplimab shows favourable signals as first-, second-line treatment alternative for NSCLC
28 Oct 2022
COVID-19 worsens antibiotic resistance
While rare, infection with antibiotic-resistant gram-negative bacteria (AR-GNB) following a positive COVID-19 diagnosis is more severe and often results in worse outcomes, according to a study presented at the recent Virtual ID Week 2022.
